Make an enquiry
Refer a patient
Patient Portal
HCP Logout

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Make an enquiry
Refer a patient

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor
2024-08-15T02:29:53.474Z

I-Mat

I-Mat
Non-melanoma (SCC, BCC, Merkel)

A randomised, placebo-controlled, phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma

A randomised, placebo-controlled, phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Non-melanoma (SCC, BCC, Merkel)

Study Phase

II

Trial Identifiers

NCT04291885

 

https://www.clinicaltrials.gov/study/NCT04291885  

GenesisCare Location(s)

GenesisCare Bundaberg

GenesisCare Bundaberg :::
Principal Investigator(s)

Dr Gerry Adams

 

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.